AdaptHealth Corp. (NASDAQ:AHCO) Receives $14.00 Consensus Price Target from Analysts

AdaptHealth Corp. (NASDAQ:AHCO) has earned an average recommendation of “Moderate Buy” from the eight ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $14.2857.

AHCO has been the topic of a number of research reports. Canaccord Genuity Group increased their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Weiss Ratings cut shares of AdaptHealth from a “hold (c-)” rating to a “sell (d)” rating in a report on Wednesday, February 25th. UBS Group dropped their price objective on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Robert W. Baird set a $18.00 price objective on shares of AdaptHealth in a report on Wednesday, May 6th. Finally, Royal Bank Of Canada increased their price objective on shares of AdaptHealth from $13.00 to $15.00 and gave the stock an “outperform” rating in a report on Monday, May 11th.

AdaptHealth Price Performance

Shares of NASDAQ:AHCO opened at $10.66 on Monday. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of -17.19, a price-to-earnings-growth ratio of 0.61 and a beta of 1.57. AdaptHealth has a 1-year low of $8.06 and a 1-year high of $13.43. The company’s fifty day moving average is $11.50 and its two-hundred day moving average is $10.48. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.71 and a current ratio of 0.92.

AdaptHealth (NASDAQ:AHCO) last issued its earnings results on Tuesday, May 5th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.13). The business had revenue of $819.80 million for the quarter, compared to analyst estimates of $796.63 million. AdaptHealth had a positive return on equity of 2.76% and a negative net margin of 2.42%.The firm’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same period last year, the company posted ($0.05) earnings per share. Equities analysts anticipate that AdaptHealth will post 0.63 EPS for the current year.

Insider Buying and Selling at AdaptHealth

In other news, major shareholder Richard M. Cashin, Jr. acquired 447,100 shares of the company’s stock in a transaction that occurred on Friday, March 20th. The shares were acquired at an average price of $9.91 per share, with a total value of $4,430,761.00. Following the acquisition, the insider directly owned 16,312,698 shares in the company, valued at approximately $161,658,837.18. The trade was a 2.82% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last 90 days, insiders have bought 2,494,518 shares of company stock valued at $24,352,291. 1.95% of the stock is owned by company insiders.

Institutional Trading of AdaptHealth

A number of large investors have recently modified their holdings of the company. PNC Financial Services Group Inc. increased its holdings in shares of AdaptHealth by 22.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after acquiring an additional 1,279 shares during the period. MetLife Investment Management LLC increased its holdings in shares of AdaptHealth by 3.1% in the 4th quarter. MetLife Investment Management LLC now owns 57,364 shares of the company’s stock worth $571,000 after acquiring an additional 1,749 shares during the period. Corient Private Wealth LLC grew its position in AdaptHealth by 8.6% in the 4th quarter. Corient Private Wealth LLC now owns 22,562 shares of the company’s stock valued at $227,000 after buying an additional 1,794 shares in the last quarter. CWM LLC grew its position in AdaptHealth by 17.5% in the 3rd quarter. CWM LLC now owns 12,306 shares of the company’s stock valued at $110,000 after buying an additional 1,835 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its position in AdaptHealth by 433.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after buying an additional 2,100 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.